Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257933 · ClinicalTrials.gov registry record · Phase 4
Oral Prednisolone Dosing in Children Hospitalized With Asthma
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 4
- Development phase
- 152
- Enrollment target
NCT00257933 is a Phase 4 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 152 participants.
The verdict
NCT00257933, a Phase 4 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 152 participants
- Enrollment target
Study Summary
This study hopes to determine the appropriate oral steroid dose for treating children hospitalized with asthma exacerbations. Practice guidelines from different countries recommend a wide range of doses, and the doses used in actual practice vary widely. There is no data on what is the most appropriate dose of prednisone (or equivalent) in this situation. We will be looking at the dose recommended by the National Asthma Education and Prevention Program guidelines, which are published by the National Heart, Lung, and Blood Institute, as compared with a lower dose which is commonly used in practice. We hypothesize that the lower dose will be no worse than the higher dose as determined primarily by duration of hospitalization.
Interventions
- DRUG Prednisolone high dose
- DRUG Prednisolone lower dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257933
The ClinicalTrials.gov registry entry for NCT00257933 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisolone high dose is the first listed.
NCT00257933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257933 about?
NCT00257933 is a clinical study titled "Oral Prednisolone Dosing in Children Hospitalized With Asthma". This study hopes to determine the appropriate oral steroid dose for treating children hospitalized with asthma exacerbations. Practice guidelines from different countries recommend a wide range of doses, and the doses used in actual practice vary widely. There is no data on what is the most appropri...
What is the current status of trial NCT00257933?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 152 participants. The study started on 2006-02. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00257933?
The interventions under investigation include: Prednisolone high dose (DRUG), Prednisolone lower dose (DRUG).
Who is sponsoring clinical trial NCT00257933?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.